I-SCREEN

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in agerelated macular degeneration (AMD) providing accessible shared care

Programme
Horizon Europe & sub-programmes
Duration
48 months (January 2024 – December 2027)
Project funding
≈ €5 million
Project partners
10
Project website
https://i-screen.eu/

What the project is about

Addressing a pressing healthcare challenge, the I-SCREEN project is committed to combating widespread vision loss caused by age-related macular degeneration (AMD). The mission involves developing an accessible and cost-effective AI-based system for early AMD detection and timely treatment. Utilising artificial intelligence, automated tools are being created for AMD detection and progression monitoring, accessible through cloud technology for real-world screening.

This initiative introduces a unique AI-powered platform designed for OCT scanners in local eye care professionals’ offices, aiming to revolutionise AMD patient care with a new concept of AI-driven shared care. With AMD affecting an estimated 67 million citizens in the EU28 (including the UK), this innovative approach leverages AI in precision image analysis to provide a therapeutic chance of benefit and accessible professional eye care for all citizens over 50 through their local optician or optometrist – an unprecedented solution to a pressing healthcare dilemma.

Coordinator

Professor Dr Ursula Schmidt-Erfurth

Medical University Vienna

Email

Your EURICE
contact

Your contact
Dr Sanja Šale
Senior Innovation Manager
Email

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

Enter THE COURT